The goal of this clinical trial is to learn about the WPM-SEMG-V2 device (Wireless Portable and Multi-Channel, WPM) designated to acquire high-density (HD) surface electromyography (sEMG) signals in healthy volunteers and post-stroke patients. The main objectives are: 1) to technically and clinically validate the WPM-SEMG-V2 device in healthy volunteers; 2) to demonstrate the clinical relevance of the HD sEMG signals to support the process of rehabilitation of post-stroke patients. Participants will be asked to perform simple exercises using the muscles of the hand or the leg in static or dynamic contractions while wearing the WPM-SEMG-V2 device.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Technical performance of the device (0 to 2)
Timeframe: 1 day
Quality of the WPM-SEMG-V2 device in the acquisition of HD sEMG signals (0 to 2)
Timeframe: 30 days
Correlation between the properties of populations of Motor Unit (MU) with the type of the stroke.
Timeframe: 30 days
Correlation between the properties of populations of Motor Unit (MU) with the severity of the stroke.
Timeframe: 30 days
Correlation between the properties of populations of Motor Unit (MU) with the location of the stroke.
Timeframe: 30 days
Percentage of tracked MU
Timeframe: 30 days